Posted on 7/30/20
Scopus BioPharma Seeks $6 Million U.S. IPO
SummaryScopus BioPharma has filed to raise $6 million in an IPO.The firm is advancing treatment candidates for lymphoma and systemic sclerosis.SCPS is thinly capitalized and is . . .
Posted on 7/29/20
BioXcel Therapeutics Prices Public Offering of Common Stock
NEW HAVEN, Conn., July 28, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, today announced the pricing of an underwritten public . . .
Posted on 7/29/20
Don’t Delay! Northern Westchester Hospital Urges Cancer Patients to Discuss Treatment with Physicians
The flattening of the curve in New York State suggests that cancer patients should begin thinking about returning for treatment, but decisions about risk versus benefit . . .
Posted on 7/29/20
Pfizer, BioNTech Choose Coronavirus Vaccine Candidate to Advance to Phase 2/3 Trial
Two companies considered to be advanced in their pursuit of a coronavirus vaccine, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), have selected one candidate for advancement to a . . .
Posted on 7/29/20
How Pfizer Beat Q2 Estimates Despite Upjohn Sales Plunging 31%
Pfizer (NYSE:PFE) has had a very eventful year so far in 2020. The COVID-19 pandemic interfered with the timing of the company's planned merger of Upjohn . . .
Posted on 7/29/20
Pfizer Rises 4.5% on Q2 Beats, Raised Guidance
Pfizer (NYSE:PFE) investors are having a good Tuesday. Their company reported second-quarter fiscal results in the morning, and while headline numbers declined, they handily beat analyst . . .
Posted on 7/29/20
Merck Declares Fresh Dividend; Yield Is 3.1%
Merck (NYSE:MRK) has elected to keep its dividend steady.On Tuesday, the sprawling pharmaceutical company said its board of directors has declared that the Q4 common stock . . .
Posted on 7/29/20
Vertex Pharmaceuticals: 67% YoY Returns With 4% Downside Risk - Calling All Medium-Term Players
Summary47.6% single-year revenue increase on the guidance of an additional 15% sales growth in 2021.67% capital gains YoY with a 4% downside risk in the same . . .
Posted on 7/29/20
Will Regeneron Help Win the Fight Against COVID-19?
With the COVID-19 pandemic showing no signs of subsiding, investing in companies developing a cure for the virus can be a great hedge for the rest . . .
Posted on 7/28/20
Zentalis Pharmaceuticals Enters into Clinical Collaboration with Eli Lilly and Company
NEW YORK & SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small . . .
Posted on 7/28/20
CorMedix Prices $20M Public Offering of Common Stock
BERKELEY HEIGHTS, N.J., July 28, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD) (the “Company”), a biopharmaceutical company focused on developing and commercializing therapeutic products . . .
Posted on 7/28/20
Viva Biotech and Schrödinger Announce Strategic Collaboration
Viva Biotech Holdings (1873.HK) and Schrödinger, Inc. (Nasdaq: SDGR) today announced a strategic collaboration to expand the reach of structure-based drug discovery by generating de novo . . .
Posted on 7/28/20
WindRose Health Investors Invests in Caregiver
WindRose Health Investors, LLC, the New York-based healthcare private equity firm, announced that it has completed the recapitalization of Caregiver Inc., a leading provider of long-term . . .
Posted on 7/28/20
DriveWealth Partners with MotivHealth
CHATHAM, N.J.--(BUSINESS WIRE)--DriveWealth, LLC, a leader in global digital trading technology, today announced their partnership with Utah-based insurance provider MotivHealth to provide an industry first, frictionless . . .
Posted on 7/28/20
Karuna Therapeutics and PsychoGenics Announce Drug Discovery Collaboration
BOSTON & PARAMUS, N.J.--(BUSINESS WIRE)--Karuna Therapeutics, Inc. (NASDAQ: KRTX), an innovative clinical-stage biopharmaceutical company committed to developing novel therapies with the potential to transform the lives . . .
Posted on 7/28/20
Pfizer Reports Second-Quarter 2020 Results
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) reported financial results for second-quarter 2020, increased its 2020 financial guidance for revenues and Adjusted diluted EPS(3) and reaffirmed all . . .
Posted on 7/28/20
Pfizer, BioNTech Choose Coronavirus Vaccine Candidate to Advance to Phase 2/3 Trial
Two companies considered to be advanced in their pursuit of a coronavirus vaccine, Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX), have selected one candidate for advancement to a . . .
Posted on 7/28/20
3 Numbers to Watch When Teladoc Releases Earnings This Week
Shares of Teladoc Health (NYSE:TDOC) are up around 170% this year, blowing past the S&P 500 and its flat performance thus far. The company's coming off . . .
Posted on 7/27/20
CorMedix Proposes Public Offering of Common Stock
BERKELEY HEIGHTS, N.J., July 27, 2020 (GLOBE NEWSWIRE) -- CorMedix Inc. (NYSE American: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for the . . .
Posted on 7/27/20
BioXcel Therapeutics Proposes Public Offering of Common Stock
NEW HAVEN, Conn., July 27, 2020 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a clinical-stage biopharmaceutical development company, today announced that it has commenced an underwritten . . .
Posted on 7/27/20
Zentalis Pharmaceuticals Proposes Public Offering of Common Stock
NEW YORK and SAN DIEGO, July 27, 2020 (GLOBE NEWSWIRE) -- Zentalis Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company focused on discovering and developing small . . .
Posted on 7/27/20
Palatin Technologies Announces Mutual Termination of License Agreement with AMAG Pharmaceuticals for Vyleesi
Palatin Technologies, Inc. (NYSE American: PTN), a specialized biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin and natriuretic peptide . . .
Posted on 7/27/20
BioHiTech Global Announces Pricing of $8.2 Million Public Offering of Common Stock
BioHiTech Global, Inc., (Nasdaq: BHTG), a technology and services company that provides cost-effective and sustainable waste management solutions, today announced the pricing of its underwritten public . . .
Posted on 7/27/20
CipherHealth Recognized as One of the Best Places to Work by Modern Healthcare for the Sixth Time
For the sixth year, CipherHealth, provider of award-winning patient engagement and communication solutions, has been recognized by Modern Healthcare as one of the Best Places to . . .
Posted on 7/27/20
BrainStorm Cell Therapeutics to Provide a Corporate and R&D Update
BrainStorm-Cell Therapeutics Inc. (NASDAQ: BCLI), a leader in developing innovative autologous cellular therapies for highly debilitating neurodegenerative diseases, announced today that the Company will hold a . . .
New York
